REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 15 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,005,748 | -16.7% | 615,932 | 0.0% | 0.00% | – |
| Q2 2023 | $3,609,361 | +50.1% | 615,932 | +7.3% | 0.00% | – |
| Q1 2023 | $2,404,096 | +21.3% | 573,770 | +23.0% | 0.00% | – |
| Q4 2022 | $1,982,272 | +206.9% | 466,417 | +14.8% | 0.00% | – |
| Q3 2022 | $646,000 | +26.4% | 406,394 | -12.6% | 0.00% | – |
| Q2 2022 | $511,000 | -55.4% | 464,808 | -0.2% | 0.00% | – |
| Q1 2022 | $1,146,000 | -19.7% | 465,508 | -5.8% | 0.00% | – |
| Q4 2021 | $1,428,000 | -31.1% | 494,408 | -2.9% | 0.00% | – |
| Q3 2021 | $2,072,000 | -19.5% | 509,056 | -3.9% | 0.00% | – |
| Q2 2021 | $2,573,000 | – | 529,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $5,832,000 | 1.16% |
| EMC Capital Management | 75,835 | $257,000 | 0.15% |
| ARMISTICE CAPITAL, LLC | 714,700 | $3,473,000 | 0.06% |
| Tower Research Capital LLC (TRC) | 12,484 | $61,000 | 0.00% |
| UBS Group AG | 2,033 | $10,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| NORTHERN TRUST CORP | 10,584 | $51,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 67,724 | $329,000 | 0.00% |
| Renaissance Technologies | 11,250 | $55,000 | 0.00% |